Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.

Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.

Item
http://www.wikidata.org/entity/Q30820946
Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell TumorsCurrent Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation.Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry.Hematopoietic stem cell gene therapy with drug resistance genes: an update.Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer.Critical issues on high-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in breast cancer patients.Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.A review of infectious complications after haploidentical hematopoietic stem cell transplantations.A review of late complications of allogeneic hematopoietic stem cell transplantations.High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer.High-dose mitoxantrone-vinblastine-cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study.Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma.Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation.A Review of Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Breast Cancer
P2860

Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.

Item
http://www.wikidata.org/entity/Q30820946
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@ast
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@en
type
label
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@ast
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@en
prefLabel
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@ast
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Autologous hematopoietic stem ...... ion (EBMT) Registry 1990-1999.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698